InvestorsHub Logo
Followers 8
Posts 1295
Boards Moderated 0
Alias Born 04/13/2016

Re: Martygx post# 11109

Monday, 02/20/2017 2:38:09 PM

Monday, February 20, 2017 2:38:09 PM

Post# of 233193
I think you are negatively biased, of course there are risks but to just assume CYDY is too small so GILD is not interested? the value is in the product - anyone buying CYDY only wants a developed pro140, they could care less about the mgmt or any other assets of the company. as for your previous post - there are risks that not every patient will show 100% efficacy and one may die for some reason. but what drug in clinical trails does not have the same risks? pro 140 just needs to meet the criteria set by the FDA - nothing more. The FDA has clearly set a reasonable path for pro140 that is more easily achieved than what it has shown in its past trials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News